PMID- 15701678 OWN - NLM STAT- MEDLINE DCOM- 20050726 LR - 20161124 IS - 0193-1849 (Print) IS - 0193-1849 (Linking) VI - 289 IP - 1 DP - 2005 Jul TI - Acute treatment with TNF-alpha attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. PG - E95-104 AB - Insulin and TNF-alpha exert opposing effects on skeletal muscle protein synthesis that are mediated in part by the rapamycin-sensitive mammalian target of rapamycin (mTOR) pathway and the PD-98059-sensitive, extracellular signal-regulated kinase (ERK)1/2 pathway. The present study examined the separate and combined effects of insulin (INS), TNF, PD-98059, or dnMEK1 adenovirus on the translational control of protein synthesis in C(2)C(12) myotubes. Cultures were treated with INS, TNF, PD-98059, dnMEK1, or a combination of INS + TNF with PD-98059 or dnMEK1. INS stimulated protein synthesis, enhanced eIF4E.eIF4G association, and eIF4G phosphorylation and repressed eIF4E.4E-BP1 association vs. control. INS also promoted phosphorylation of ERK1/2, S6K1, and 4E-BP1 and dephosphorylation of eIF4E. TNF alone did not have an effect on protein synthesis (vs. control), eIF4E.eIF4G association, or the phosphorylation of eIF4G, S6K1, or 4E-BP1, although it transiently increased ERK1/2 and eIF4E phosphorylation. When myotubes were treated with TNF + INS, the cytokine blocked the insulin-induced stimulation of protein synthesis. This appeared to be due to an attenuation of insulin-stimulated eIF4E.eIF4G association, because other stimulatory effects of INS, e.g., phosphorylation of ERK1/2, 4E-BP1, S6K1, eIF4G, and eIF4E and eIF4E.4E-BP1 association, were unaffected. Finally, treatment of myotubes with PD-98059 or dnMEK1 adenovirus before TNF + INS addition resulted in a derepression of protein synthesis and the association of eIF4G with eIF4E. These findings suggest that TNF abrogates insulin-induced stimulation of protein synthesis in myotubes through a decrease in eIF4F complex assembly independently of S6K1 and 4E-BP1 signaling and dependently on a MEK1-sensitive signaling pathway. FAU - Williamson, David L AU - Williamson DL AD - Department of Cellular and Molecular Physiology, H166, The Pennsylvania State University College of Medicine, 500 Univ. Dr., Hershey, PA 17033, USA. FAU - Kimball, Scot R AU - Kimball SR FAU - Jefferson, Leonard S AU - Jefferson LS LA - eng GR - DK-15658/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050208 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (Drug Combinations) RN - 0 (Insulin) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.12.2 (MAP Kinase Kinase 1) RN - EC 2.7.12.2 (Map2k1 protein, mouse) SB - IM MH - Animals MH - Cell Line MH - Dose-Response Relationship, Drug MH - Drug Combinations MH - Insulin/*pharmacology MH - MAP Kinase Kinase 1/*metabolism MH - Mice MH - Muscle Fibers, Skeletal/drug effects/*metabolism MH - Muscle, Skeletal/drug effects/*metabolism MH - Protein Biosynthesis/drug effects/*physiology MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2005/02/11 09:00 MHDA- 2005/07/27 09:00 CRDT- 2005/02/11 09:00 PHST- 2005/02/11 09:00 [pubmed] PHST- 2005/07/27 09:00 [medline] PHST- 2005/02/11 09:00 [entrez] AID - 00397.2004 [pii] AID - 10.1152/ajpendo.00397.2004 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E95-104. doi: 10.1152/ajpendo.00397.2004. Epub 2005 Feb 8.